High field magnetic resonance imaging evaluation of superparamagnetic iron oxide nanoparticles in a permanent rat myocardial infarction
- PMID: 12595793
- DOI: 10.1097/01.RLI.0000052979.96332.90
High field magnetic resonance imaging evaluation of superparamagnetic iron oxide nanoparticles in a permanent rat myocardial infarction
Abstract
Rationale and objectives: The purpose of this study was to evaluate superparamagnetic iron oxide (SPIO) nanoparticles to discriminate infarcted from normal tissue after myocardial infarction using high field MR imaging (7 tesla).
Materials and methods: Permanent myocardial infarction was induced in rats. SPIO nanoparticles (1 mg Fe/kg) were assessed with T1-weighted gradient echo sequence to visualize the myocardial infarction 48 hours after ligature (n = 6). Furthermore, MR Imaging was performed using a T2-weighted RARE sequence and nanoparticles were injected (5 or 10 mg Fe/kg) on 36 rats 5, 24 or 48 hours after infarction.
Results: No changes in contrast between normal and infarcted myocardium was observed after nanoparticle injection on T1-weighted images. However, nanoparticles induced a significant contrast increase between normal and infarcted myocardium on T2-weighted images whatever the delay between infarction and imaging (2.99 +/- 1.66 preinjection vs. 7.82 +/- 1.96 after SPIO injection at a dose of 5 mg Fe/kg 5 hours postinfarction, P = 0.0001).
Conclusions: Nanoparticle injection made it possible to discriminate normal from infarcted myocardium on T2-weighted images. However, the high magnetic field prevented the visualization of the T1 effect of SPIO nanoparticles.
Similar articles
-
Magnetic resonance imaging (MRI) of inflamed myocardium using iron oxide nanoparticles in patients with acute myocardial infarction - preliminary results.Int J Cardiol. 2013 Feb 20;163(2):175-82. doi: 10.1016/j.ijcard.2011.06.004. Int J Cardiol. 2013. PMID: 21689857 Clinical Trial.
-
Mapping cyclic change of regional myocardial blood volume using steady-state susceptibility effect of iron oxide nanoparticles.J Magn Reson Imaging. 2004 Jan;19(1):50-8. doi: 10.1002/jmri.10426. J Magn Reson Imaging. 2004. PMID: 14696220
-
Low dose gadobenate dimeglumine for imaging of chronic myocardial infarction in comparison with standard dose gadopentetate dimeglumine.Invest Radiol. 2009 Feb;44(2):95-104. doi: 10.1097/RLI.0b013e3181911eab. Invest Radiol. 2009. PMID: 19077911 Clinical Trial.
-
Current applications of nanotechnology for magnetic resonance imaging of apoptosis.Methods Mol Biol. 2010;624:325-42. doi: 10.1007/978-1-60761-609-2_22. Methods Mol Biol. 2010. PMID: 20217606 Review.
-
[MR imaging--evaluation of viability in infarcted myocardium by MRI].Nihon Rinsho. 1994 Aug;52 Suppl(Pt 2):621-5. Nihon Rinsho. 1994. PMID: 12440035 Review. Japanese. No abstract available.
Cited by
-
In vivo delivery, pharmacokinetics, biodistribution and toxicity of iron oxide nanoparticles.Chem Soc Rev. 2015 Dec 7;44(23):8576-607. doi: 10.1039/c5cs00541h. Epub 2015 Sep 21. Chem Soc Rev. 2015. PMID: 26390044 Free PMC article. Review.
-
Nanomaterials as Novel Cardiovascular Theranostics.Pharmaceutics. 2021 Mar 7;13(3):348. doi: 10.3390/pharmaceutics13030348. Pharmaceutics. 2021. PMID: 33799932 Free PMC article. Review.
-
Nanoparticles as magnetic resonance imaging contrast agents for vascular and cardiac diseases.Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2011 Mar-Apr;3(2):146-161. doi: 10.1002/wnan.114. Epub 2010 Oct 21. Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2011. PMID: 20967875 Free PMC article. Review.
-
Bioabsorbable stent quo vadis: a case for nano-theranostics.Theranostics. 2014 Feb 22;4(5):514-33. doi: 10.7150/thno.8137. eCollection 2014. Theranostics. 2014. PMID: 24672583 Free PMC article. Review.
-
Nanoparticles for diagnosis and therapy of atherosclerosis and myocardial infarction: evolution toward prospective theranostic approaches.Theranostics. 2018 Sep 9;8(17):4710-4732. doi: 10.7150/thno.26284. eCollection 2018. Theranostics. 2018. PMID: 30279733 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical